Sinibaldi-Vallebona P - Search Results

1

Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity.

Petrone V, Fanelli M, Giudice M, Toschi N, Conti A, Maracchioni C, Iannetta M, Resta C, Cipriani C, Miele MT, Amati F, Andreoni M, Sarmati L, Rogliani P, Novelli G, Garaci E, Rasi G, Sinibaldi-Vallebona P, Minutolo A, Matteucci C, Balestrieri E, Grelli S. Petrone V, et al. Among authors: sinibaldi vallebona p. Front Microbiol. 2023 May 22;14:1155624. doi: 10.3389/fmicb.2023.1155624. eCollection 2023. Front Microbiol. 2023. PMID: 37283924 Free PMC article.

2

Cytoplasmic localization of anthracycline antitumor drugs conjugated with reduced glutathione: a possible correlation with multidrug resistance mechanisms.

Serafino A, Sinibaldi-Vallebona P, Gaudiano G, Koch TH, Rasi G, Garaci E, Ravagnan G. Serafino A, et al. Anticancer Res. 1998 Mar-Apr;18(2A):1159-66. Anticancer Res. 1998. PMID: 9615782

3

Differential expression of a new tumor-associated antigen, TLP, during human colorectal cancer tumorigenesis.

Guadagni F, Graziano P, Roselli M, Mariotti S, Bernard P, Sinibaldi-Vallebona P, Rasi G, Garaci E. Guadagni F, et al. Am J Pathol. 1999 Apr;154(4):993-9. doi: 10.1016/S0002-9440(10)65351-5. Am J Pathol. 1999. PMID: 10233837 Free PMC article.

4

Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer.

Garaci E, Pica F, Sinibaldi-Vallebona P, Pierimarchi P, Mastino A, Matteucci C, Rasi G. Garaci E, et al. Int Immunopharmacol. 2003 Aug;3(8):1145-50. doi: 10.1016/S1567-5769(03)00053-5. Int Immunopharmacol. 2003. PMID: 12860169 Review.

5

Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma.

Rasi G, Pierimarchi P, Sinibaldi Vallebona P, Colella F, Garaci E. Rasi G, et al. Int Immunopharmacol. 2003 Aug;3(8):1169-76. doi: 10.1016/S1567-5769(03)00012-2. Int Immunopharmacol. 2003. PMID: 12860172 Review.

6

Vaccination with a synthetic nonapeptide expressed in human tumors prevents colorectal cancer liver metastases in syngeneic rats.

Sinibaldi Vallebona P, Rasi G, Pierimarchi P, Bernard P, Guarino E, Guadagni F, Garaci E. Sinibaldi Vallebona P, et al. Int J Cancer. 2004 May 20;110(1):70-5. doi: 10.1002/ijc.20063. Int J Cancer. 2004. PMID: 15054870 Free article.

7

Differentiation of human melanoma cells induced by cyanidin-3-O-beta-glucopyranoside.

Serafino A, Sinibaldi-Vallebona P, Lazzarino G, Tavazzi B, Rasi G, Pierimarchi P, Andreola F, Moroni G, Galvano G, Galvano F, Garaci E. Serafino A, et al. FASEB J. 2004 Dec;18(15):1940-2. doi: 10.1096/fj.04-1925fje. Epub 2004 Sep 27. FASEB J. 2004. PMID: 15451888

8

A role for endogenous reverse transcriptase in tumorigenesis and as a target in differentiating cancer therapy.

Sinibaldi-Vallebona P, Lavia P, Garaci E, Spadafora C. Sinibaldi-Vallebona P, et al. Genes Chromosomes Cancer. 2006 Jan;45(1):1-10. doi: 10.1002/gcc.20266. Genes Chromosomes Cancer. 2006. PMID: 16175572 Review.

9

Thymosin alpha 1: from bench to bedside.

Garaci E, Favalli C, Pica F, Sinibaldi Vallebona P, Palamara AT, Matteucci C, Pierimarchi P, Serafino A, Mastino A, Bistoni F, Romani L, Rasi G. Garaci E, et al. Ann N Y Acad Sci. 2007 Sep;1112:225-34. doi: 10.1196/annals.1415.044. Epub 2007 Jun 28. Ann N Y Acad Sci. 2007. PMID: 17600290

10

Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1.

Matteucci C, Minutolo A, Sinibaldi-Vallebona P, Palamara AT, Rasi G, Mastino A, Garaci E. Matteucci C, et al. Ann N Y Acad Sci. 2010 Apr;1194:6-19. doi: 10.1111/j.1749-6632.2010.05484.x. Ann N Y Acad Sci. 2010. PMID: 20536445 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page